CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Trillium Therapeutics Inc Company Snapshot
Trillium Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Trillium Therapeutics Inc with three other companies in this sector in CANADA : StageZero Life Sciences Ltd (2019 sales of 183,531.75 Canadian Dollars [US$139,039.98 ] ), Novoheart Holdings Inc (165,031.00 Canadian Dollars [US$125,024.18 ] ), and Arch Biopartners Inc (93,876.00 Canadian Dollars [US$71,118.58 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Trillium Therapeutics Inc
  Stock Performance Chart for Trillium Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 19.50
(Figures in Canadian Dollars)
1 Week -3.7%   13 Weeks -6.7%  
4 Weeks 77.3%   52 Weeks 4,775.0%  
 
Trillium Therapeutics Inc Key Data:
  Ticker: TRIL Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 164,076
(Year Ending Jan 2020).
Employees: 7
  Currency: Canadian Dollars Market Cap: 1,649,319,185
  Fiscal Yr Ends: December Shares Outstanding: 84,580,471
  Share Type: Closely Held Shares: 15,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.